Rinri Therapeutics, a world leading spinout company from the University of Sheffield dedicated to transforming sensorineural ...

Today, on World Bronchiectasis Day, the American Lung Association is launching a new campaign to support people living with bronchiectasis, which is a chronic and progressive lung condition that ...

UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural ...

Galapagos announces leadership transition. European biotechnology company Galapagos completed a significant leadership ...

The site was created by Boehringer Ingelheim after a survey identified knowledge gaps among owners on many health topics ...

Total adverse events of heart failure or all-cause mortality were reduced with empagliflozin, regardless of kidney function.

DOHA: Weber Shandwick MENAT has launched the second edition of InfluAnswer Arabia, a report informed by the perspectives of content creators, that ...

With CT scans picking up more cases of sclerosing mesenteritis, be prepared to diagnose this poorly understood autoimmune ...

TOKYO -- German drugmaker Boehringer Ingelheim plans to invest a total of 300 million euros ($346 million) in its plant in Japan from 2023 to 2028 as it moves to make the facility a production base ...

Boehringer Ingelheim’s Spevigo (spesolimab) has been recommended by the National Institute for Health and Care Excellence ...

What happens when data projects forget the people who use them? A Disconnect. Boehringer Ingelheim turned things around by ...